Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026?
One-OffHealth & Medicine3MonFutuurVerifizierte AuflösungsdatenAktuelle implizite WahrscheinlichkeitNein 93%
Marktqualitat
31 / 100
Niedrige Qualität24h-Volumen
—
Liquidität
308,4 €
Niedrige LiquiditätTrader
8
Kommentare
0
Marktdaten
Aktualisiert vor 1 Minute
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will artificial blood be used to treat a patient by the end of 2026?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurWill artificial blood be used to treat a patient by the end of 2027?
Manifold MarketsHow many patients will be treated under right-to-try in Montana within 2026?
FutuurPeer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
Manifold MarketsWill Artificial wombs for premature babies be tested in humans by the end of 2026?
FutuurRegeln
Auflösungskriterien sind für diesen Markt noch nicht verfügbar. Dieser Abschnitt wird nach den nächsten Aktualisierungen gefüllt, sobald die Quellregeln gespeichert sind.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026??
- Futuur bewertet No mit 93% (Stand: 8. September 2026).
- Wann wird Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? entschieden?
- Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? soll am 31. Dezember 2026 entschieden werden.